Literature DB >> 26782643

The tumor suppressor role of miR-4782-3p in hepatocellular carcinoma.

Wentao Bo1, Yong Hu1, Xielin Feng1, Hui Zhang1, Lang Tian1, Aixiang Liu1.   

Abstract

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortalities in China. Although advances have been made in treatments, the prognosis of HCC patients has not improved significantly. MicroRNAs (miRNA) play important roles in all stage of the progress of HCC. miR-4782-3p takes part in the pathogenesis of non-small cell lung cancer (NSCLC). However, the role of miR-4782-3p in HCC remains unknown. In the present study, we found that miR-4782-3p had low expression in HCC tissues. The low expression of miR-4782-3p indicated shorter survival of HCC patients. Moreover, the low expression of miR-4782-3p promoted HCC cells growth and inhibited cell apoptosis. We confirmed that USP14 was targeted by miR-4782-3p in HCC cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26782643     DOI: 10.3892/or.2016.4568

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.

Authors:  Yue Zhang; Chao Wei; Cong-Cong Guo; Rong-Xiu Bi; Jin Xie; Dong-Hui Guan; Chuan-Hua Yang; Yue-Hua Jiang
Journal:  Oncotarget       Date:  2017-09-14

2.  Expression of microRNA-3133 correlates with the prognosis in patients with clear cell renal cell carcinoma.

Authors:  Xiaoyan Chen
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

3.  Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma.

Authors:  Fang Wang; Peter Breslin S J; Wei Qiu
Journal:  Liver Res       Date:  2021-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.